Selected Research Support
Veteran's Affairs
“Management and control of coexisting chronic diseases in COPD patients”
Funding Period: 1/1/08-12/31/09
UIC Subcontract PI: Pickard
The aims of this study include the following: (1)describe and characterize factors associated with the treatment and control of diabetes and hyperlipidemia in patients with COPD; (2) evaluate the association of management of diabetes and hyperlipidemia with short-term (e.g. hospitalization) and long-term (e.g. mortality) outcomes in patients with COPD; and (3) examine adverse consequences associated with management of diabetes and hyperlipidemia in patients with COPD
Agency for Healthcare Research and Quality
DEcIDE Task Order #2: “Design and evaluation of a medication therapy management program to improve patient safety in Medicare beneficiaries”
Funding period: 9/30/05-5/30/09
Project PI: Touchette
The aims of this multi-center prospective study include the evaluation of various components of a community-based pharmacy Medication Therapy Management program.
Agency for Healthcare Research and Quality
DEcIDE Task Order #4 / Work Assignment #1: “Comparative Effectiveness of Anticholinergic Medications in Patients with Chronic Obstructive Pulmonary Disease (COPD)”
Funding period: 8/1/07-6/30/08;
Project PI: Pickard.
The aim of this study is to evaluate the incremental effectiveness of anticholinergic medications in terms of impact on mortality, exacerbations and hospitalizations in patients with COPD.
Pfizer
Estimation of a Utility-Based Algorithm for the EORTC-QLQ
Funding period 4/1/07-3/31/08;
Project PI: Pickard.
The aim of this study is to estimate a preference-based scoring algorithm for a descriptive system based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (QLQ30), a cancer specific measure of HRQL widely used to assess patient-reported quality of life outcomes in clinical trials
Agency for Healthcare Research and Quality
Medical Economics Center for Education and Research on Therapeutics (CERT): “Validating Performance Measures for Patients Hospitalized with COPD Exacerbations”
Funding Period: 9/1/07-8/31/11
UIC Subcontract PI: Schumock
The aims of this study are to evaluate the validity (sensitivity and specificity) of identifying patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations and, separately, hospitalized for heart failure using administrative data compared to chart review.
Agency for Healthcare Research and Quality
Medical Economics Center for Education and Research on Therapeutics (CERT): “Electronic Record Interventions to Address Off-Label Prescribing”
Funding Period: 9/1/07-8/31/11
UIC Subcontract PI: Walton
This is a pilot project to develop an electronic based intervention for gathering data regarding off-label drug use in an inpatient setting.
Agency for Healthcare Research and Quality
Medical Economics Center for Education and Research on Therapeutics (CERT): “Using Social Network Analysis to Guide Quality Improvement Team Formation”
Funding Period: 9/1/07-8/31/11
UIC Subcontract PI: Schumock
The aims of this study to develop and pilot a highly innovative approach to use of social network analysis to help hospitals develop more effective teams to improve quality.
Agency for Healthcare Research and Quality UIC Centers for Research and Education in Therapeutics (CERT): “Design, Implementation, and Dissemination of Medication Prescribing Guidelines in a National Consortium of Health-Systems: Translation of Evidence into Practice”
Funding Period: 9/1/07-8/31/11
Project PI: Schumock
The aims of this study are to develop, disseminate, implement, and evaluate clinical prescribing guidelines in a national consortium of hospitals, and to evaluate the impact of the guidelines on clinical outcomes, quality measures, and costs.
Agency for Healthcare Research and Quality
UIC Centers for Research and Education in Therapeutics (CERT): “Pharmacoeconomics: Empowerment tool for Formulary Process”
Funding Period: 9/1/07-8/31/11
Project Co-Investigators: Walton and Touchette
The aims of this study include conducting a total of 18 expert pharmacoeconomic consultations and analyses directed at practical questions posed by select formulary committees.